STOCK TITAN
  1. Home
  2. Sec-filings
  3. GDRX
  4. [8-K] GoodRx Holdings, Inc. Reports Material Event

GoodRx (NASDAQ: GDRX) CAO Romin Nabiey to depart in 2026

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

GoodRx Holdings, Inc. announced that Chief Accounting Officer Romin Nabiey has submitted his resignation, effective April 3, 2026, to pursue other opportunities. He will remain with the company through June 8, 2026 to help transition his responsibilities. The company stated that his resignation is not due to any disagreement regarding its operations, policies, or practices, and expressed appreciation for his years of service.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Understanding 8-K Material Events →
0001809519FALSE2701 Olympic BoulevardSanta MonicaCalifornia00018095192026-03-242026-03-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 8-K
________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 24, 2026
________________________________________
GoodRx Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
________________________________________
Delaware
001-39549
47-5104396
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2701 Olympic Boulevard
Santa Monica, California
90404
(Address of Principal Executive
Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (855) 268-2822
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per
share
GDRX
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
Chief Accounting Officer Resignation
On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, Inc. (the
“Company”), effective April 3, 2026 in order to pursue other opportunities. Mr. Nabiey will remain an employee of the
Company through June 8, 2026 to support the transition of his responsibilities. Mr. Nabiey’s resignation was not a result of
any disagreement between the Company and Mr. Nabiey on any matter related to the operations, policies, or practices of
the Company. The Company thanks Mr. Nabiey for his years of contribution and service to the Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
GOODRX HOLDINGS, INC.
Date:
March 27, 2026
By:
/s/ Christopher McGinnis
Name: Christopher McGinnis
Title: Chief Financial Officer & Treasurer

Source: View Original Filing on SEC EDGAR

FAQ

What executive change did GoodRx (GDRX) disclose in this 8-K?

GoodRx disclosed that Chief Accounting Officer Romin Nabiey has resigned. His resignation is effective April 3, 2026, with continued employment through June 8, 2026, to support the transition of his responsibilities within the company.

When is GoodRx CAO Romin Nabiey’s resignation effective?

Romin Nabiey’s resignation as Chief Accounting Officer is effective April 3, 2026. He will remain an employee until June 8, 2026, to assist with transitioning his accounting and financial reporting responsibilities at GoodRx Holdings, Inc.

How long will GoodRx’s departing CAO stay to support the transition?

Although his resignation is effective April 3, 2026, Romin Nabiey will remain employed at GoodRx through June 8, 2026. During this period, he will support the orderly transition of his Chief Accounting Officer responsibilities.

What reason did GoodRx give for Romin Nabiey’s departure as CAO?

GoodRx reported that Romin Nabiey resigned as Chief Accounting Officer to pursue other opportunities. The company did not provide additional detail, but it explicitly noted that his resignation was not due to any disagreement with the organization.

Who signed GoodRx’s 8-K reporting the CAO resignation?

The 8-K reporting the resignation was signed on behalf of GoodRx Holdings, Inc. by Christopher McGinnis. He is identified in the filing as the company’s Chief Financial Officer and Treasurer, acting as the authorized signatory.

Filing Exhibits & Attachments

3 documents

Other Documents